Does Primaquine Phosphate Interact with Ergot Type Oxytocic Drugs?
CDI records a major classification for Primaquine Phosphate and Ergot Type Oxytocic Drugs. The stored summary is: As CYP3A4 substrates with minimal concentration changes that may lead to serious adverse reactions, concomitant use warrants caution. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
What To Tell Your Doctor or Pharmacist
If you are taking Primaquine Phosphate and your doctor is considering prescribing Ergot Type Oxytocic Drugs (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider